VAERS reports by lot

Moderna COVID-19 lot 042B212A: VAERS reports

66 VAERS reports list lot 042B212A as a Moderna COVID-19 vaccine, received between 2021-04-14 and 2023-02-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
66
Reports
11%
Marked serious
4
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological4722%
General / Systemic (non-local)4421%
Gastrointestinal3014%
Cardiac / Cardiovascular2411%
Dermatological (non-injection-site)157%
Injection-site / Local reaction157%
Musculoskeletal115%
Allergic / Anaphylactic84%
Respiratory63%
Thrombotic / Hematological42%
Psychiatric / Neuropsychiatric42%
Reproductive / Menstrual31%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts26
Rhode Island5
South Carolina5
Illinois5
Kentucky5
New Hampshire3
New Jersey3
California3
West Virginia2
Maryland1
Missouri1
Virginia1

Reports by month received

2021-0421
2021-0514
2021-063
2021-076
2021-0810
2021-102
2021-112
2022-044
2022-051
2022-081
2022-121
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.